{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:00:50Z","timestamp":1791489650496,"version":"4.3.4"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":222,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004775","name":"Gansu Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["25JRRA872"],"award-info":[{"award-number":["25JRRA872"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101373","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T12:13:45Z","timestamp":1787055225000},"page":"101373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Metformin in cancer immunotherapy: knowledge mapping of an evolving field through bibliometric analysis (2007\u20132026)"],"prefix":"10.1016","volume":"49","author":[{"given":"Mao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kefei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1869-8420","authenticated-orcid":false,"given":"Kehao","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqin","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6159-0209","authenticated-orcid":false,"given":"Jing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ctarc.2026.101373_bib0001","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/cncr.35111","article-title":"Metformin as a booster or obstacle of immunotherapy in patients with non-small cell lung cancer and diabetes mellitus [J]","volume":"130","author":"Guan","year":"2024","journal-title":"Cancer"},{"key":"10.1016\/j.ctarc.2026.101373_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110528","article-title":"Metformin as a booster of cancer immunotherapy [J]","volume":"121","author":"Panaampon","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101373_bib0003","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005719","article-title":"Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression [J]","volume":"11","author":"Finisguerra","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"11","key":"10.1016\/j.ctarc.2026.101373_bib0004","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002614","article-title":"Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapy [J]","volume":"9","author":"Munoz","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101373_bib0005","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1995999","article-title":"Metformin promotes anticancer activity of NK cells in a p38 MAPK dependent manner [J]","volume":"10","author":"Xia","year":"2021","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101373_bib0006","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12943-025-02302-0","article-title":"Inhibition of 6-phosphogluconate dehydrogenase suppresses esophageal squamous cell carcinoma growth and enhances the anti-tumor effects of metformin via the AMPK\/mTOR pathway [J]","volume":"24","author":"Wang","year":"2025","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101373_bib0007","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005719","article-title":"Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression [J]","volume":"11","author":"Finisguerra","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101373_bib0008","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008053","article-title":"Respiratory complex I regulates dendritic cell maturation in explant model of human tumor immune microenvironment [J]","volume":"12","author":"Turpin","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"10","key":"10.1016\/j.ctarc.2026.101373_bib0009","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1007\/s11605-022-05354-5","article-title":"Association of tumor pathological response with the use of metformin during neoadjuvant chemoradiotherapy in rectal and esophageal\/gastroesophageal cancer patients: a systematic review and meta-analysis [J]","volume":"26","author":"Sakamoto","year":"2022","journal-title":"J. Gastrointest. Surg."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101373_bib0010","doi-asserted-by":"crossref","DOI":"10.3390\/ph15050626","article-title":"Metformin and cancer, an ambiguanidous relationship [J]","volume":"15","author":"Skuli","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101373_bib0011","doi-asserted-by":"crossref","first-page":"904","DOI":"10.2337\/dci22-0047","article-title":"Metformin and cancer: solutions to a real-world evidence failure [J]","volume":"46","author":"Yu","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ctarc.2026.101373_bib0012","article-title":"Harnessing big data to characterize immune-related adverse events [J]","author":"Ying","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101373_bib0013","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/S40037-021-00695-4","article-title":"Bibliometrics: methods for studying academic publishing [J]","volume":"11","author":"Ninkov","year":"2022","journal-title":"Perspect. Med. Educ."},{"key":"10.1016\/j.ctarc.2026.101373_bib0014","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.cie.2017.08.033","article-title":"Forty years of computers & industrial engineering: a bibliometric analysis [J]","volume":"113","author":"Cancino","year":"2017","journal-title":"Comput. Ind. Eng."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101373_bib0015","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","article-title":"Software survey: VOSviewer, a computer program for bibliometric mapping [J]","volume":"84","author":"van Eck","year":"2010","journal-title":"Scientometrics"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101373_bib0016","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0306-4573(00)00051-0","article-title":"Bibliometric cartography of information retrieval research by using co-word analysis [J]","volume":"37","author":"Ding","year":"2001","journal-title":"Inf. Process. Manag."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101373_bib0017","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s11845-018-1936-5","article-title":"Current concepts on bibliometrics: a brief review about impact factor, Eigenfactor score, CiteScore, SCImago Journal Rank, Source-Normalised Impact per Paper, H-index, and alternative metrics [J]","volume":"188","author":"Roldan-Valadez","year":"2019","journal-title":"Ir. J. Med. Sci."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101373_bib0018","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1097\/JS9.0000000000000492","article-title":"Evolutionary patterns and research frontiers in neoadjuvant immunotherapy: a bibliometric analysis [J]","volume":"109","author":"Jiang","year":"2023","journal-title":"Int. J. Surg."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101373_bib0019","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1096\/fj.07-9492LSF","article-title":"Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses [J]","volume":"22","author":"Falagas","year":"2008","journal-title":"FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.ctarc.2026.101373_bib0020","unstructured":"Pilkington A. Bibexcel-quick start guide to bibliometrics and citation analysis, F, 2018 [C]."},{"key":"10.1016\/j.ctarc.2026.101373_bib0021","article-title":"Investigating the structure of regional innovation system research through keyword co-occurrence and social network analysis [J]. Innovation-the","author":"Pei Chun","year":"2010","journal-title":"Eur. J. Soc. Sci. Res."},{"key":"10.1016\/j.ctarc.2026.101373_bib0022","article-title":"The relationship between the research performance of scientists and their position in co-authorship networks in three fields [J]","author":"Mar\u00eda","year":"2015","journal-title":"J. Informetr."},{"key":"10.1016\/j.ctarc.2026.101373_bib0023","series-title":"AMIA Annual Symposium proceedings AMIA Symposium","first-page":"724","article-title":"CiteSpace II: visualization and knowledge discovery in bibliographic databases [J]","volume":"2005","author":"Synnestvedt","year":"2005"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101373_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2018.07.030","article-title":"Metformin promotes antitumor immunity via endoplasmic-reticulum-associated degradation of PD-L1 [J]","volume":"71","author":"Cha","year":"2018","journal-title":"Mol. Cell"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101373_bib58","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1073\/pnas.1417636112","article-title":"Immune-mediated antitumor effect by type 2 diabetes drug, metformin","volume":"112","author":"Eikawa","year":"2015","journal-title":"Proc. Natl Acad. Sci. U S A"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101373_bib59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1158\/2326-6066.CIR-16-0103","article-title":"Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia","volume":"5","author":"Scharping","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ctarc.2026.101373_bib60","doi-asserted-by":"crossref","unstructured":"Wei Z, Zhang X, Yong T, et al. Boosting anti-PD-1 therapy with metformin-loaded macrophage-derived microparticles. Nat. Commun. 2021;12(1):440. 10.1038\/s41467-020-20723-x.","DOI":"10.1038\/s41467-020-20723-x"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101373_bib0025","doi-asserted-by":"crossref","DOI":"10.1158\/2326-6066.CIR-16-0103","article-title":"Efficacy of PD-1 blockade is potentiated by metformin-induced reduction of tumor hypoxia [J]","volume":"5","author":"Scharping","year":"2017","journal-title":"Cancer Immunol. Res."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101373_bib0026","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1073\/pnas.1417636112","article-title":"Immune-mediated antitumor effect by type 2 diabetes drug, metformin [J]","volume":"112","author":"Eikawa","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101373_bib0027","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1158\/2326-6066.CIR-16-0103","article-title":"Efficacy of PD-1 blockade is potentiated by metformin-induced reduction of tumor hypoxia [J]","volume":"5","author":"Scharping","year":"2016","journal-title":"Cancer Immunol. Res."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101373_bib0028","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.molcel.2018.07.030","article-title":"Metformin promotes antitumor immunity via endoplasmic-reticulum-associated degradation of PD-L1 [J]","volume":"71","author":"Cha","year":"2018","journal-title":"Mol. Cell"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101373_bib0029","doi-asserted-by":"crossref","first-page":"e861","DOI":"10.1016\/j.cllc.2018.07.010","article-title":"Study protocol: phase-ib trial of nivolumab combined with metformin for refractory\/recurrent solid tumors [J]","volume":"19","author":"Kubo","year":"2018","journal-title":"Clin. Lung Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101373_bib0030","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-018-0375-1","article-title":"Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1\/anti-CTLA-4) in metastatic malignant melanoma [J]","volume":"6","author":"Afzal","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ctarc.2026.101373_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110528","article-title":"Metformin as a booster of cancer immunotherapy [J]","volume":"121","author":"Panaampon","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101373_bib0032","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/s41401-020-00508-0","article-title":"Metformin and cancer immunity [J]","volume":"41","author":"Ma","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101373_bib0033","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.fertnstert.2018.05.006","article-title":"Personalized medicine: motivation, challenges, and progress [J]","volume":"109","author":"Goetz","year":"2018","journal-title":"Fertil. Steril."},{"issue":"17","key":"10.1016\/j.ctarc.2026.101373_bib0034","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713353","article-title":"The impact of metformin on tumor-infiltrated immune cells: preclinical and clinical studies [J]","volume":"24","author":"Abdelmoneim","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101373_bib0035","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1633235","article-title":"Metformin as an archetype immuno-metabolic adjuvant for cancer immunotherapy [J]","volume":"8","author":"Verdura","year":"2019","journal-title":"Oncoimmunology"},{"issue":"11","key":"10.1016\/j.ctarc.2026.101373_bib0036","doi-asserted-by":"crossref","first-page":"811","DOI":"10.5966\/sctm.2012-0058","article-title":"Glioma-initiating cell elimination by metformin activation of FOXO3 via AMPK [J]","volume":"1","author":"Sato","year":"2012","journal-title":"Stem Cells Transl. Med."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101373_bib0037","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002614","article-title":"Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapy [J]","volume":"9","author":"Munoz","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"22","key":"10.1016\/j.ctarc.2026.101373_bib0038","doi-asserted-by":"crossref","first-page":"10804","DOI":"10.1158\/0008-5472.CAN-07-2310","article-title":"Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells [J]","volume":"67","author":"Dowling","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101373_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122052","article-title":"Metformin-containing hydrogel scaffold to augment CAR-T therapy against post-surgical solid tumors [J]","volume":"295","author":"Chao","year":"2023","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.ctarc.2026.101373_bib0040","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.4049\/jimmunol.1901213","article-title":"Metformin enhances the antitumor activity of CD8+ T lymphocytes via the AMPK-miR-107-Eomes-PD-1 pathway [J]","volume":"204","author":"Zhang","year":"2020","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101373_bib0041","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1007\/s00262-022-03363-6","article-title":"Effect of metformin on outcomes of patients treated with immune checkpoint inhibitors: a retrospective cohort study [J]","volume":"72","author":"Chiang","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101373_bib0042","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41571-021-00514-z","article-title":"Planning for tomorrow: global cancer incidence and the role of prevention 2020-2070 [J]","volume":"18","author":"Soerjomataram","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2026.101373_bib0043","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcancer.2021.04.006","article-title":"AMPK signaling and its targeting in cancer progression and treatment [J]","volume":"85","author":"Hsu","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"7977","key":"10.1016\/j.ctarc.2026.101373_bib0044","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41586-023-06482-x","article-title":"CRISPR screens decode cancer cell pathways that trigger \u03b3\u03b4 T cell detection [J]","volume":"621","author":"Mamedov","year":"2023","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.ctarc.2026.101373_bib0045","doi-asserted-by":"crossref","DOI":"10.3390\/nano12244494","article-title":"Nanoparticles in drug delivery: from history to therapeutic applications [J]","volume":"12","author":"Afzal","year":"2022","journal-title":"Nanomater. (Basel)"},{"key":"10.1016\/j.ctarc.2026.101373_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120680","article-title":"Combined regimens of cisplatin and metformin in cancer therapy: a systematic review and meta-analysis [J]","volume":"304","author":"Jafarzadeh","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.ctarc.2026.101373_bib0047","article-title":"Metformin-mediated immunosuppressive microenvironment remodeling in combination with chemotherapy via a spatial-specific multi-responsive carrier-free self-assembled nanoparticle [J]","author":"Yujun","year":"2024","journal-title":"Adv. Funct. Mater."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101373_bib0048","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1084\/jem.20131916","article-title":"PD-L1 is a novel direct target of HIF-1\u03b1, and its blockade under hypoxia enhanced MDSC-mediated T cell activation [J]","volume":"211","author":"Noman","year":"2014","journal-title":"J. Exp. Med."},{"issue":"7851","key":"10.1016\/j.ctarc.2026.101373_bib0049","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","article-title":"Metabolic support of tumour-infiltrating regulatory T cells by lactic acid [J]","volume":"591","author":"Watson","year":"2021","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.ctarc.2026.101373_bib0050","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1039\/D2BM00988A","article-title":"Metformin reprograms tumor microenvironment and boosts chemoimmunotherapy in colorectal cancer [J]","volume":"10","author":"Ni","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ctarc.2026.101373_bib0051","doi-asserted-by":"crossref","DOI":"10.1111\/dom.15689","article-title":"Integrated biomarker profiling for predicting the response of type 2 diabetes to metformin [J]","author":"Long","year":"2024","journal-title":"Diabetes Obes. Metab."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101373_bib0052","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054331","article-title":"A novel combination of sotorasib and metformin enhances cytotoxicity and apoptosis in kras-mutated non-small cell lung cancer cell lines through MAPK and P70S6K inhibition [J]","volume":"24","author":"Barrios-Bernal","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101373_bib0053","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70508","article-title":"Targeting cancer stem cells and hedgehog pathway: enhancing cisplatin efficacy in ovarian cancer with metformin [J]","volume":"29","author":"Jafarzadeh","year":"2025","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ctarc.2026.101373_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.101946","article-title":"Synergistic anticancer effects of doxorubicin and metformin combination therapy: a systematic review [J]","volume":"45","author":"Jalali","year":"2024","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.ctarc.2026.101373_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2025.102438","article-title":"The clinical potentials of combining paclitaxel-based chemotherapy regimen with metformin in cancer treatment: a systematic review and Meta-analysis [J]","volume":"59","author":"Omidi Sarajar","year":"2025","journal-title":"Transl. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101373_bib0056","doi-asserted-by":"crossref","DOI":"10.1177\/2158244019829575","article-title":"Citations, citation indicators, and research quality: an overview of basic concepts and theories [J]","volume":"9","author":"Aksnes","year":"2019","journal-title":"Sage Open"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226002844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226002844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:42:24Z","timestamp":1791488544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226002844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":59,"alternative-id":["S2468294226002844"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101373","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin in cancer immunotherapy: knowledge mapping of an evolving field through bibliometric analysis (2007\u20132026)","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101373","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101373"}}